Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Management of hypertension in the very old: aggressive reduction of blood pressure is harmful in most patients

Journal of Human Hypertension volume 34, pages 557–559 (2020)Cite this article

Subjects

Abstract

Arterial hypertension is particularly prevalent in the elderly and treatment is required according to the literature. Treatment in subjects between 65 and 80 years of age resembles by characteristics and results that obtained in younger population. The treatment of arterial hypertension in the very elderly differs in a relevant percentage of them. It is quite similar in those with a good physical fitness with or without cardiovascular disease. A series of factors as the presence of real sustained hypertension, orthostatic hypotension, frailty and disability, and the boundary of safety recommended by international recent guidelines analysed here are relevant to characterize a clearly elevated risk of complications in the remaining very elderly patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985;1:1349–54.

    Article  CAS  Google Scholar 

  2. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA. 1996;276:1886–92.

    Article  CAS  Google Scholar 

  3. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281–5.

    Article  Google Scholar 

  4. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757–64.

    Article  CAS  Google Scholar 

  5. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N. Engl J Med. 2008;358:1887–98.

    Article  CAS  Google Scholar 

  6. Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl J Med. 2015;373:2103–16.

    Article  CAS  Google Scholar 

  7. Whelton PK, Carey RM, Aronow WS, Casey DR Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e13–5.

    CAS  PubMed  Google Scholar 

  8. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

    Article  Google Scholar 

  9. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102:1139–44.

    Article  CAS  Google Scholar 

  10. Bulpitt CJ, Beckett N, Peters R, Staessen JA. Response to HYVET ambulatory blood pressure substudy. Hypertension. 2013;61:e43.

    CAS  PubMed  Google Scholar 

  11. Bulpitt CJ, Beckett N, Peters R, Staessen JA, Wang JG, Comsa M, et al. Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension. 2013;61:89–94.

    Article  CAS  Google Scholar 

  12. Kaplan NM. New issues in the treatment of isolated systolic hypertension. Circulation. 2000;102:1079–81.

    Article  CAS  Google Scholar 

  13. Ferrucci L, Furberg CD, Penninx BW, DiBari M, Williamson JD, Guralnik JM, et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation. 2001;104:1923–6.

    Article  CAS  Google Scholar 

  14. Atkins D, Hanusa B, Sefcik T, Kapoor W. Syncope and orthostatic hypotension. Am J Med. 1991;91:179–85.

    Article  CAS  Google Scholar 

  15. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001.

    Article  Google Scholar 

  16. Molander L, Lövheim H, Norman T, Nordström P, Gustafson Y. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc. 2008;56:1853–9.

    Article  Google Scholar 

  17. Gijón-Conde T, Graciani A, López-García E, García-Esquinas E, Laclaustra M, Ruilope LM, et al. Frailty, disability, and ambulatory blood pressure in older adults. J Am Med Dir Assoc. 2018;19:433–8.

    Article  Google Scholar 

  18. Ruilope LM, Ruiz-Hurtado G, Barderas MG, de la Cruz JJ, Lucia A, de la Sierra A, et al. Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals. Hypertension. 2019;74:130–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain

    L. M. Ruilope & G. Ruiz-Hurtado

  2. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain

    L. M. Ruilope & G. Ruiz-Hurtado

  3. Universidad Europea de Madrid, Madrid, Spain

    L. M. Ruilope

Authors
  1. L. M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Ruiz-Hurtado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. M. Ruilope.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruilope, L.M., Ruiz-Hurtado, G. Management of hypertension in the very old: aggressive reduction of blood pressure is harmful in most patients. J Hum Hypertens 34, 557–559 (2020). https://doi.org/10.1038/s41371-020-0346-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-020-0346-0

This article is cited by

Search

Advanced search

Quick links